Innate Pharma SA SEC filings IPHYF

Innate Pharma SA has 339 filings in SEC EDGAR's recent list, going back to Jan 31, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Innate Pharma SA SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 5, 2026 Nov 5, 2026
6-K Current report (foreign issuer) Oct 27, 2026 Oct 27, 2026
6-K Current report (foreign issuer) Oct 21, 2026 Oct 21, 2026
6-K Current report (foreign issuer) Oct 20, 2026 Oct 20, 2026
6-K Current report (foreign issuer) Sep 17, 2026 Sep 17, 2026
6-K Current report (foreign issuer) Sep 17, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 17, 2026 Sep 16, 2026
6-K Current report (foreign issuer) Sep 10, 2026 Sep 10, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
6-K Current report (foreign issuer) Aug 19, 2026 Aug 19, 2026
6-K Current report (foreign issuer) Aug 14, 2026 Aug 14, 2026
6-K Current report (foreign issuer) Aug 10, 2026 Aug 10, 2026
6-K Current report (foreign issuer) Jul 23, 2026 Jul 23, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 22, 2026 —
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 19, 2026 May 19, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) May 12, 2026 May 12, 2026
6-K Current report (foreign issuer) May 6, 2026 May 6, 2026
6-K Current report (foreign issuer) Apr 23, 2026 Apr 23, 2026
6-K Current report (foreign issuer) Apr 17, 2026 Apr 17, 2026
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 10, 2026 —
6-K Current report (foreign issuer) Apr 8, 2026 Apr 8, 2026
6-K Current report (foreign issuer) Apr 3, 2026 Apr 3, 2026
6-K Current report (foreign issuer) Apr 2, 2026 Apr 2, 2026
20-F Annual report (foreign issuer) Apr 1, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 26, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 19, 2026 Mar 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 4, 2026 —
6-K Current report (foreign issuer) Feb 18, 2026 Feb 18, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 6, 2026 —
6-K Current report (foreign issuer) Jan 7, 2026 Jan 7, 2026
6-K Current report (foreign issuer) Dec 22, 2025 Dec 22, 2025
6-K Current report (foreign issuer) Dec 11, 2025 Dec 11, 2025
6-K Current report (foreign issuer) Nov 28, 2025 Nov 28, 2025
6-K Current report (foreign issuer) Nov 17, 2025 Nov 17, 2025
6-K Current report (foreign issuer) Nov 13, 2025 Nov 13, 2025
6-K Current report (foreign issuer) Nov 10, 2025 Nov 10, 2025
6-K Current report (foreign issuer) Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 21, 2025 —
6-K Current report (foreign issuer) Oct 15, 2025 Oct 14, 2025
6-K Current report (foreign issuer) Sep 17, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Sep 17, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Sep 15, 2025 Sep 15, 2025
6-K Current report (foreign issuer) Sep 10, 2025 Sep 10, 2025
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
6-K Current report (foreign issuer) Aug 4, 2025 Aug 4, 2025
6-K Current report (foreign issuer) Jul 29, 2025 Jul 29, 2025
6-K Current report (foreign issuer) Jul 7, 2025 Jul 4, 2025
6-K Current report (foreign issuer) Jun 17, 2025 Jun 17, 2025
6-K Current report (foreign issuer) Jun 13, 2025 Jun 13, 2025
144 Notice of proposed sale May 30, 2025 —
6-K Current report (foreign issuer) May 27, 2025 May 27, 2025
6-K Current report (foreign issuer) May 23, 2025 May 23, 2025
6-K Current report (foreign issuer) May 23, 2025 May 23, 2025
6-K Current report (foreign issuer) May 19, 2025 May 19, 2025
6-K Current report (foreign issuer) May 15, 2025 May 15, 2025
6-K Current report (foreign issuer) May 13, 2025 May 13, 2025
6-K Current report (foreign issuer) May 12, 2025 May 12, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 7, 2025 —
6-K Current report (foreign issuer) May 6, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 30, 2025 Apr 30, 2025
20-F Annual report (foreign issuer) Apr 30, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2025 —
6-K Current report (foreign issuer) Apr 29, 2025 Apr 29, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2025 —
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
6-K Current report (foreign issuer) Apr 24, 2025 Apr 24, 2025
6-K Current report (foreign issuer) Apr 23, 2025 Apr 23, 2025
6-K Current report (foreign issuer) Apr 16, 2025 Apr 16, 2025
6-K Current report (foreign issuer) Apr 16, 2025 Apr 16, 2025
6-K Current report (foreign issuer) Apr 3, 2025 Apr 3, 2025
6-K Current report (foreign issuer) Mar 27, 2025 Mar 27, 2025
6-K Current report (foreign issuer) Mar 26, 2025 Mar 26, 2025
6-K Current report (foreign issuer) Mar 25, 2025 Mar 25, 2025
6-K Current report (foreign issuer) Mar 20, 2025 Mar 20, 2025
6-K Current report (foreign issuer) Feb 27, 2025 Feb 27, 2025
6-K Current report (foreign issuer) Feb 18, 2025 Feb 17, 2025
6-K Current report (foreign issuer) Jan 27, 2025 Jan 27, 2025
6-K Current report (foreign issuer) Jan 21, 2025 Jan 21, 2025
6-K Current report (foreign issuer) Jan 16, 2025 Jan 16, 2025
6-K Current report (foreign issuer) Jan 10, 2025 Jan 10, 2025
6-K Current report (foreign issuer) Dec 20, 2024 Dec 20, 2024
6-K Current report (foreign issuer) Dec 9, 2024 Dec 9, 2024
6-K Current report (foreign issuer) Dec 6, 2024 Dec 6, 2024
6-K Current report (foreign issuer) Dec 3, 2024 Dec 3, 2024
6-K Current report (foreign issuer) Nov 20, 2024 Nov 20, 2024
6-K Current report (foreign issuer) Nov 19, 2024 Nov 19, 2024
6-K Current report (foreign issuer) Nov 13, 2024 Nov 13, 2024
6-K Current report (foreign issuer) Nov 8, 2024 Nov 8, 2024
6-K Current report (foreign issuer) Nov 7, 2024 Nov 7, 2024
6-K Current report (foreign issuer) Oct 29, 2024 Oct 29, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 14, 2024
6-K Current report (foreign issuer) Sep 30, 2024 Sep 30, 2024
6-K Current report (foreign issuer) Sep 23, 2024 Sep 23, 2024
6-K Current report (foreign issuer) Sep 12, 2024 Sep 12, 2024
6-K Current report (foreign issuer) Sep 12, 2024 Jun 30, 2024
S-8 Employee stock plan registration Sep 11, 2024 —
6-K Current report (foreign issuer) Sep 9, 2024 Sep 9, 2024
6-K Current report (foreign issuer) Sep 5, 2024 Sep 5, 2024
6-K Current report (foreign issuer) Sep 4, 2024 Sep 4, 2024
6-K Current report (foreign issuer) Jul 25, 2024 Jul 25, 2024
6-K Current report (foreign issuer) Jun 18, 2024 Jun 18, 2024
6-K Current report (foreign issuer) Jun 17, 2024 Jun 17, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 4, 2024
6-K Current report (foreign issuer) May 28, 2024 May 28, 2024
6-K Current report (foreign issuer) May 24, 2024 May 24, 2024
6-K Current report (foreign issuer) May 23, 2024 May 23, 2024
6-K Current report (foreign issuer) May 15, 2024 May 15, 2024
6-K Current report (foreign issuer) May 14, 2024 May 14, 2024
6-K Current report (foreign issuer) May 7, 2024 May 7, 2024
6-K Current report (foreign issuer) Apr 15, 2024 Apr 15, 2024
6-K Current report (foreign issuer) Apr 15, 2024 Apr 15, 2024
6-K Current report (foreign issuer) Apr 10, 2024 Apr 10, 2024
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 21, 2024 Mar 21, 2024
6-K Current report (foreign issuer) Mar 21, 2024 Mar 21, 2024
6-K Current report (foreign issuer) Mar 19, 2024 Mar 19, 2024
6-K Current report (foreign issuer) Mar 14, 2024 Mar 14, 2024
6-K Current report (foreign issuer) Mar 6, 2024 Mar 6, 2024
6-K Current report (foreign issuer) Mar 6, 2024 Mar 6, 2024
6-K Current report (foreign issuer) Feb 21, 2024 Feb 21, 2024
6-K Current report (foreign issuer) Feb 6, 2024 Feb 6, 2024
424B5 Prospectus supplement Feb 6, 2024 —
EFFECT Filing Jan 16, 2024 —
6-K Current report (foreign issuer) Jan 12, 2024 Jan 12, 2024
CORRESP Letter to the SEC Jan 11, 2024 —
6-K Current report (foreign issuer) Jan 5, 2024 Jan 4, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Jan 4, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Jan 4, 2024
UPLOAD Letter from the SEC Dec 26, 2023 —
F-3 Shelf registration (foreign issuer) Dec 20, 2023 —
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
6-K Current report (foreign issuer) Dec 19, 2023 Dec 19, 2023
6-K Current report (foreign issuer) Dec 18, 2023 Dec 18, 2023
6-K Current report (foreign issuer) Dec 11, 2023 Dec 10, 2023
6-K Current report (foreign issuer) Dec 11, 2023 Dec 11, 2023
6-K Current report (foreign issuer) Nov 27, 2023 Nov 27, 2023
6-K Current report (foreign issuer) Nov 14, 2023 Nov 14, 2023
6-K Current report (foreign issuer) Nov 7, 2023 Nov 7, 2023
6-K Current report (foreign issuer) Nov 3, 2023 Nov 3, 2023
6-K Current report (foreign issuer) Oct 27, 2023 Oct 27, 2023
6-K Current report (foreign issuer) Oct 19, 2023 Oct 19, 2023
6-K Current report (foreign issuer) Oct 16, 2023 Oct 16, 2023
6-K Current report (foreign issuer) Oct 10, 2023 Oct 9, 2023
6-K Current report (foreign issuer) Oct 5, 2023 Oct 5, 2023
6-K Current report (foreign issuer) Sep 22, 2023 Sep 22, 2023
6-K Current report (foreign issuer) Sep 14, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Sep 14, 2023 Sep 14, 2023
6-K Current report (foreign issuer) Aug 29, 2023 Aug 29, 2023
6-K Current report (foreign issuer) Aug 10, 2023 Aug 10, 2023
6-K Current report (foreign issuer) Jul 11, 2023 Jul 11, 2023
6-K Current report (foreign issuer) Jul 7, 2023 Jul 7, 2023
6-K Current report (foreign issuer) Jun 26, 2023 Jun 26, 2023
6-K Current report (foreign issuer) Jun 16, 2023 Jun 16, 2023
6-K Current report (foreign issuer) Jun 12, 2023 Jun 12, 2023
6-K Current report (foreign issuer) Jun 12, 2023 Jun 10, 2023
6-K Current report (foreign issuer) Jun 8, 2023 Jun 8, 2023
6-K Current report (foreign issuer) Jun 7, 2023 Jun 7, 2023
6-K Current report (foreign issuer) May 26, 2023 May 26, 2023
6-K Current report (foreign issuer) May 23, 2023 May 22, 2023
6-K Current report (foreign issuer) May 15, 2023 May 15, 2023
6-K Current report (foreign issuer) May 12, 2023 May 12, 2023
6-K Current report (foreign issuer) May 10, 2023 May 10, 2023
6-K Current report (foreign issuer) May 9, 2023 May 9, 2023
6-K Current report (foreign issuer) May 3, 2023 May 3, 2023
6-K Current report (foreign issuer) May 3, 2023 May 3, 2023
6-K Current report (foreign issuer) Apr 26, 2023 Apr 26, 2023
6-K Current report (foreign issuer) Apr 26, 2023 Apr 26, 2023
424B5 Prospectus supplement Apr 26, 2023 —
6-K Current report (foreign issuer) Apr 21, 2023 Apr 21, 2023
20-F/A Amended annual report (foreign issuer) Apr 20, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Apr 18, 2023 Apr 18, 2023
6-K Current report (foreign issuer) Apr 7, 2023 Apr 7, 2023
20-F Annual report (foreign issuer) Apr 6, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Apr 6, 2023 Apr 6, 2023
6-K Current report (foreign issuer) Apr 3, 2023 Apr 3, 2023
6-K Current report (foreign issuer) Mar 23, 2023 Mar 23, 2023
6-K Current report (foreign issuer) Mar 20, 2023 Mar 20, 2023
6-K Current report (foreign issuer) Mar 16, 2023 Mar 16, 2023
6-K Current report (foreign issuer) Mar 13, 2023 Mar 13, 2023
6-K Current report (foreign issuer) Feb 21, 2023 Feb 21, 2023
6-K Current report (foreign issuer) Feb 7, 2023 Feb 7, 2023
6-K Current report (foreign issuer) Jan 25, 2023 Jan 25, 2023
6-K Current report (foreign issuer) Jan 17, 2023 Jan 16, 2023
6-K Current report (foreign issuer) Dec 19, 2022 Dec 19, 2022
6-K Current report (foreign issuer) Dec 12, 2022 Dec 12, 2022
6-K Current report (foreign issuer) Dec 12, 2022 Dec 10, 2022
6-K Current report (foreign issuer) Dec 9, 2022 Dec 9, 2022
SC 13D/A Amended ownership over 5% (active) Dec 6, 2022 —
6-K Current report (foreign issuer) Dec 1, 2022 Dec 1, 2022
6-K Current report (foreign issuer) Nov 14, 2022 Nov 14, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Nov 4, 2022
6-K Current report (foreign issuer) Nov 4, 2022 Nov 3, 2022
6-K Current report (foreign issuer) Nov 2, 2022 Nov 2, 2022
SC 13D/A Amended ownership over 5% (active) Oct 21, 2022 —
6-K Current report (foreign issuer) Oct 20, 2022 Oct 20, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IPHA (Nasdaq), IPHYF (OTC)
Fiscal year ends
December 31
Incorporated in
France
Headquarters
Marseille
SEC filer status
Accelerated filer
SEC CIK
1598599
Former names
Innate Pharma, SA (until Jan 31, 2014)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.